Insecticides (india) Limited · NSE:INSECTICID

Insecticides (india) — Q1 FY2020 Earnings Presentation

17 slides from Insecticides (india)'s earnings presentation, November 2020

  1. Slide 1: Q1 FY2020 Earnings Presentation

    (BSE: 532851 NSE: INSECTICID) Q1 FY2020 Earnings Presentation

  2. Slide 2: Q1 FY2020 Highlights

    Q1 FY2020 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 12.4% 13.6% 5.7% 3,584 631 359 340 3,189 556 10.7% 10.0% 17.4% 17.6% Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 EBITDA Margin (%) PAT Margin (%) Quarterly Highlights: • Revenue growth of 12.4% was pr

  3. Slide 3: Products Freshness Index

    Products Freshness Index Proven track record of successful new product launches exhibits IIL’s strong R&D capabilities and continues to provide competitive edge 535 478 70 Revenue from new product launches (Rs. Cr.) 420 66 89 299 131 148 90 11 13 9 221 33 38 10 45 34 172 30 89 66 41 65 60 69 166 172

  4. Slide 4: Management Commentary

    Management Commentary Commenting on the results, Mr. Rajesh Aggarwal, Managing Director, said: “FY2020 started on a negative note with delay in sowing season due to 15-20 days postponement in monsoon. Rainfall for the season was also deficit by 16%, which further aggravated the decline in demand for

  5. Slide 5: Growth Strategy

    Growth Strategy Optimum Capital Structure and Phase out Generic Products Backward and Forward Integration Operational Efficiency • Gradual reduction in the sale of • Moving on the strategic path of • Strong cash flow generation Generic products (high volume-low backward and forward integration • Cap

  6. Slide 6: Business Overview

    Business Overview Insecticides India - A Leading Agro Chemicals Manufacturing Company Engaged in the manufacturing and marketing of crop-protection products Rs. 358 Cr 60,000+ Four product categories: Insecticides, Herbicides, Fungicides, Q1 FY20 Sales Retail Outlets Biologicals and Plant Growth Reg

  7. Slide 7: Capabilities and Geographical Presence

    Capabilities and Geographical Presence R&D Manufacturing • NABL QC Labs • 5 Formulations plant • In-house R&D Centre 01 02 • 2 Technical synthesis plants • JV with OAT Agrio Co. • 1 Biological manufacturing plant* Japan for dedicated R&D Centre Development Marketing & Training 04 03 • Sale & market

  8. Slide 8: Leading Maharatna Brands

    Leading Maharatna Brands PULSOR : Systemic fungicide with preventive and curative action; controls Rice Sheath Blight LETHAL : Organo-phosphorus group of insecticides; controls insects through contact, stomach and vapour action GREEN LABEL : Specialist of weed control in paddy; in line with ‘Make in

  9. Slide 9: Research & Development

    Research & Development State-of-the-art in house R&D centre established in 2005, augmented by product innovation R&D center, formulation R&D centre and biological R&D centre • Approved by DSIR, Ministry of Science and Technology 6 Patents Received • Working on new formulations and new combination pr

  10. Slide 10: Financial Performance

    Financial Performance Q1 Y-o-Y Q4 Q-o-Q Full Year Y-o-Y (Rs. Million) FY2020 FY2019 Growth(%) FY2019 Growth(%) FY2019 FY2018 Growth(%) Operating Revenue (net of excise) 3,584 3,189 12.4% 1,989 80.1% 11,919 10,733 11.1% Other Income 12 2 543.4% 10 20.4% 23 32 (28.8)% Total Revenue 3,595 3,191 12.7% 1

  11. Slide 11: Financial Trends - Quarterly

    Financial Trends - Quarterly Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 12.4% 13.6% 5.7% Y-o-Y Y-o-Y Y-o-Y 4,583 3,584 692 430 3,189 631 359 556 340 286 2,157 1,989 17.4% 320 289 169 14.3% 17.6% 10.7% 14.8% 9.4% 15.1% 7.8% 10.0% 14.5% Q1 FY19 Q2 FY19 Q3 FY19 Q4 FY19 Q

  12. Slide 12: Segment Reporting – Q1 FY2020

    Segment Reporting – Q1 FY2020 Gross Sales by Product Category Gross Sales by Segment 4% 3% 2% 26% 49% Insecticides B2C 44% Herbicides 72% B2B Fungicides Exports PGR Gross Sales vs Internal Consumption Breakdown of Top Seller Range in B2C Sales 45% 45% Maharatna 55% 55% Internal Products Consumption

  13. Slide 13: Segment Reporting – Q1 FY2020

    Segment Reporting – Q1 FY2020 Gross Sales by Segment (Rs. Mn) Gross Sales by Emphasized Product Category (Rs. Mn) +7% -8% -14% +0.2% +14% 2,782 2,595 1,535 1,350 1,245 1,248 1,076 992 104 90 B2C B2B Exports Maharatna Products Other Products Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 • Growth in sales of B2C se

  14. Slide 14: Recent Announcements

    Recent Announcements Patent received for Insecticidal Combination and Process of "Suspension Concentra TE (Sc) Formulation Comprising Buprofezin And Fipronil" Term of 20 years, from 2nd December 2014 • Sold under the Brand Name "AIKIDO“ • Launched in technical collaboration with Nihon Nohyaku, Japan

  15. Slide 15: FY2020 Outlook

    FY2020 Outlook Opportunities Quarterly Outlook India is currently the world’s fourth largest producer of The quarter is expected to be positive with forecasted near agrochemicals. Favourable manufacturing opportunities for normal rainfall and delayed-yet-better sowing season agrochemical companies i

  16. Slide 16: Disclaimer

    Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Insecticides India Limited (“Insecticides India” or the Company) future b

  17. Slide 17: Insecticides (India) Ltd.

    Insecticides (India) Ltd. (CIN: L65991DLl996PLC083909) 401-402, Lusa Tower Azadpur Commercial Complex Delhi - 110033 Telefax: +91 11 - 27679700 - 04 (5 Lines) info@insecticidesindia.com www.insecticidesindia.com

Insecticides (India) — Q1 FY2020 Earnings Presentation on 6ix